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Background: Dietary strategies seem to be the most prescribed therapy in order to counteract obesity regarding
not only calorie restriction, but also bioactive ingredients and the composition of the consumed foods. Dietary total
antioxidant capacity (TAC) is gaining importance in order to assess the quality of the diet.
Methods: Ninety-six obese adults presenting metabolic syndrome (MetS) symptoms completed an 8-week
intervention trial to evaluate the effects of a novel dietary program with changes in the nutrient distribution and
meal frequency and to compare it with a dietary pattern based on the American Heart Association (AHA)
guidelines.
Anthropometric and biochemical parameters were assessed at baseline and at the endpoint of the study, in
addition to 48-hours food dietary records.
Results: Both diets equally (p > 0.05) improved MetS manifestations. Dietary TAC was the component which
showed the major influence on body weight (p = 0.034), body mass index (p = 0.026), waist circumference
(p = 0.083) and fat mass (p = 0.015) reductions. Transaminases (ALT and AST) levels (p = 0.062 and p = 0.004,
respectively) were associated with lower TAC values.
Conclusion: RESMENA diet was as effective as AHA pattern for reducing MetS features. Dietary TAC was the most
contributing factor involved in body weight and obesity related markers reduction.
Trial registration: www.clinicaltrials.gov; NCT01087086
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profileBackground
The World Health Organization (WHO) estimates that
at least 300 million people are obese nowadays [1].
Obesity, is strongly associated with comorbidities such
as impaired glucose tolerance or diabetes, insulin resist-
ance, dyslipidemia, hypertension, nonalcoholic fatty
liver disease, hyperuricemia, and prothrombotic and* Correspondence: jalfmtz@unav.es
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distribution, and reproduction in any mediumproinflammatory states, which are related to the onset
of metabolic syndrome (MetS) [2-4]. Also according to
the WHO estimations, obesity prevalence rates will tend
to increase in the next years. So that new effective
proposals are needed in order to prevent/counteract the
obesity onset and spread.
Dietary strategies are one of the most prescribed ther-
apies to prevent/counteract overweight and obesity [5].
While dietetic programs have traditionally focused on
calorie restriction, new nutritional alternatives are
nowadays being investigated. They entail macronutrient
distribution [6], meal frequency [7], consumption ofCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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acids [9], glycemic index (GI)/glycemic load (GL) [10]
or the dietary total antioxidant capacity (TAC) [11].
Dietary TAC is considered an appropriate approach to
measure the cumulative antioxidant properties of food
[12], despite its controversial use at evaluating the role
of antioxidants in vivo [13]. Oxidative stress is suggested
to be involved in the onset of several obesity-related
disorders such as hypertension, dyslipidemia, type-2
Diabetes Mellitus and MetS [11]. In this context, dietary
TAC is gaining importance as a valuable tool to investi-
gate the relationship between diet and oxidative stress-
related diseases [14]. Furthermore, the influence of the
dietary TAC has been poorly investigated in the context
of MetS.
Many studies have separately examined the impact of
different dietary components, such as macronutrient
distribution [15], meal frequency [7], fiber [8], n-3 fatty
acids [16], GI/GL [17] or dietary TAC [18]. However, to
date, they have not been integrated together on a dietetic
plan based on habitual foods intake to combat excessive fat
deposition. In this context, the RESMENA-S (MEtabolic
Syndrome REduction in NAvarra-Spain) study (www.
clinicaltrials.gov; NCT01087086) [19] aimed at evaluatingFigure 1 Flowchart of the study subjects from advertisement throughthe effect of a novel dietary strategy involving a modified
macronutrient distribution, higher meal frequency,
increased fiber and n-3 fatty acids consumption, low GI/
GL and high TAC food and at comparing it with the
American Heart Association (AHA) guidelines, which is
currently considered as a reference dietary pattern to
reduce fat mass content and improve MetS markers [20].
Methods
Study population
One hundred and five (56 Male and 49 Female) caucasian
adults (49 ± 10 years old) presenting obesity determined
by a Body Mass Index (BMI) higher than 30 Kg/m2
(mean BMI = 35.85 ± 4.67 kg/m2) and at least two MetS
signs according to the International Diabetes Federation
criteria [21] were enrolled in the study and 96 of them
completed the trial (Figure 1). The presence of psychi-
atric disturbances, eating disorders, chronic diseases
related with the metabolism of nutrients, major body
weight changes in the last three months and difficulties
in changing food habits were considered as exclusion
criteria. Subjects were recruited through local newspaper
advertisements and the Department database. All subjects
gave written informed consent (www.clinicaltrials.gov;to the end of the 8-week intervention.
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the University of Navarra (065/2009) and in accordance
with the Declaration of Helsinki. There were 9 dropouts
along the study period. Baseline characteristics are
presented in Table 1.
Study protocol
A randomized, controlled trial was designed to compare
the effect of two dietary strategies for weight loss with
different macronutrient distribution on anthropometric
measurements and biochemical markers in obese subjects
with MetS manifestations. Participants were randomly
assigned to the control or the experimental diet (Figure 1).
The study was of six months duration in two sequential
periods: one intervention period of 8 weeks in which
subjects received nutritional assessment every 15 days
followed by a self-control period of 4 months in which
subjects followed the first period learned-habits. This
work reports on the 8-weeks findings.
At each visit, anthropometric assessments and body
composition by bioimpedance were measured. Fasting
blood and 24-h urine samples were collected and body
composition by Dual-energy X-ray Absorptiometry
(DXA) was measured at baseline and at the endpoint of
the intervention period.
Diets
Two energy-restricted diets were prescribed and
compared. An energy restriction of 30% was applied to
the total energy requirements of each patient. Resting
metabolic rate was calculated using the Harris-Benedict
equation where the Wilkens adjusted weight was applied.
Then, physical activity factor was considered in order to
calculate total energy requirements according to the
“Food and Nutrition Board, National Research Council:
Recommended Dietary Allowances: 10th ed.” [22]. The
Control diet was based on the AHA guidelines [20],
including 3–5 meals/day, a macronutrient distribution
of 50–55% total caloric value from carbohydrates, 15%Table 1 Selected anthropometric characteristics of the whole
Variable Total (n = 96)
Sex -
Age (years) 49 ± 10
Weight (kg) 99.73 ± 17.85
Height (m) 1.67 ± 0.11
BMI (kg/m2) 35.84 ± 4.67
Waist circumference (cm) 111.10 ± 12.80
Waist/Hip ratio 0.96 ± 0.10
BMI, Body Mass Index.
For the sex variable it is reported the frequency of men and females. Mean and sta
p-value: Comparison between men and women baseline characteristics.
p < 0.05 was set-up as statistically significant.from proteins and 30% from lipids, a healthy fatty acids
profile, an intake of fiber of 20–25 g/day and a choles-
terol recommendation of < 300 mg/day (Table 2). The
RESMENA diet was composed of 7 meals/day including
breakfast, lunch, dinner, two snacks in the morning and
other two in the afternoon. The macronutrient distribu-
tion was as following: 40% total caloric value from
carbohydrates, 30% from proteins and 30% from lipids.
This pattern also maintained a healthy fatty acids pro-
file, an input of fiber of 20–25 g/day and a cholesterol
content of < 300 mg/day. It included an increased input
of n-3 fatty acids, an increased amount of natural
antioxidants and focused on low GI/GL carbohydrates
(Table 2).
Participants were provided a 7-day menu plan in the
RESMENA group and a food exchange system plan in the
Control group, as previously described [2]. Usual diet was
assessed with a semiquantitative 136-item food frequency
questionnaire previously validated in Spain for energy and
nutrient intake [14]. A 48-hour weighed food record was
required at the beginning and at the end of the study. Diet
composition was analyzed using the DIAL software (Alce
Ingenieria, Madrid, Spain). The sum of eicosapentaenoic
fatty acid and docosahexaenoic fatty acid (EPA +DHA)
obtained by the DIAL program was used to estimate n-3
fatty acids consumption. The Healthy Eating Index (HEI)
was calculated using also the DIAL software as described
elsewhere [23]. The program gives different values
between 0 and 100 considering the servings per day of
cereals, vegetables, fruits, dairy products and meat. It also
takes into account the percentage of energy provided by
total and saturated fats, the amount of cholesterol and
sodium per day and the variety of the diet. The final score
was classified in five categories: > 80 points indicates
“excellent diet”; 71–80 points = “very good diet”; 61–70
points = “good diet”; 51–60 = “acceptable diet” and 0–50
points = “inadequate diet”. Protein Quality (PQ) was
defined as the ratio of essential amino acid to total dietary
protein [24]. Dietary TAC was calculated using the listsample and categorized by gender at baseline
Male Female p
51 45 -
48 ± 9 50 ± 10 0.194
108.28 ± 15.94 90.03 ± 14.76 <0.001
1.74 ± 0.08 1.58 ± 0.07 <0.001
35.75 ± 4.38 35.96 ± 5.02 0.822
116.27 ± 10.04 105.24 ± 13.16 <0.001
1.03 ± 0.07 0.89 ± 0.08 <0.001
ndard deviation data are shown concerning the remaining variables.
Table 2 Comparisons of the habitual intake, the scheduled diets, the final intake and the adherence
Variable Control group (n = 48) RESMENA group (n = 48)
Habitual
intake (day 0)
Scheduled
diet
Final intake
(day 60)
Habitual
intake (day 0)
pa Scheduled
diet
pb Final intake
(day 60)
pc
Energy (kcal/day) 2103 ± 451 1412 ± 177 1352 ± 284 2277 ± 566 0.099 1395 ± 188 0.649 1337 ± 289 0.808
CHO (g/day) 186.74 ± 58.90
(35.52%)
178.58 ± 20.15
(50.59%)
132.37 ± 35.33$$$
(39.16%)
201.66 ± 65.30
(35.43%)
0.243 128.65 ± 15.97
(36.89%)
<0.001 114.55 ± 31.10$$
(34.26%)
0.013
Protein (g/day) 93.58 ± 21.63
(17.80%)
57.01 ± 5.78
(16.14%)
60.83 ± 17.16
(18.00%)
95.01 ± 20.06
(16.69%)
0.738 99.54 ± 13.43
(28.54%)
<0.001 78.20 ± 17.46$$$
(23.39%)
<0.001
PQ 0.30 ± 0.05 0.31 ± 0.01 0.30 ± 0.05$ 0.30 ± 0.05 0.594 0.34 ± 0.01 <0.001 0.28 ± 0.05$$$ 0.070
Protein/CHO 0.54 ± 0.18 0.32 ± 0.01 0.48 ± 0.18$$$ 0.50 ± 0.13 0.224 0.77 ± 0.01 <0.001 0.70 ± 0.15$$ <0.001
Total fats (g/day) 97.29 ± 27.00
(41.64%)
46.02 ± 8.69
(29.33%)
59.09 ± 15.51$$$
(39.33%)
110.26 ± 31.84
(43.58%)
0.034 46.98 ± 7.07
(30.31%)
0.554 56.58 ± 17.28$$$
(38.08%)
0.497
SFA (g/day) 28.89 ± 10.13
(12.36%)
14.02 ± 2.44
(8.94%)
14.48 ± 5.47
(9.64%)
34.85 ± 13.64
(13.76%)
0.017 12.70 ± 1.86
(8.19%)
0.004 16.08 ± 5.80$$
$(10.82%)
0.181
MUFA (g/day) 47.35 ± 12.76
(20.26%)
20.59 ± 4.51
(13.12%)
32.25 ± 9.18$$$
(21.47%)
51.90 ± 15.42
(20.52%)
0.118 18.96 ± 3.11
(12.23%)
0.042 24.65 ± 7.80$$$
(16.59%)
<0.001
PUFA (g/day) 12.58 ± 3.80
(5.38%)
7.54 ± 1.20
(4.81%)
7.65 ± 2.87
(5.09%)
13.92 ± 3.79
(5.50%)
0.088 10.77 ± 1.31
(6.95%)
<0.001 10.91 ± 5.56
(7.34%)
0.001
n3-FA 0.46 ± 0.54 0.20 ± 0.05 0.20 ± 0.44 0.28 ± 0.43 0.079 0.83 ± 0.30 <0.001 0.37 ± 0.49$$$ 0.096
Cholesterol
(mg/day)
363.43 ± 142.46 157.94 ± 18.44 206.68 ± 140.82$$$ 424.43 ± 162.31 0.053 275.75 ± 46.51 <0.001 241.21 ± 105.00 0.196
Fiber (g/day) 20.07 ± 8.77 27.57 ± 1.33 18.75 ± 8.50$$$ 21.66 ± 9.69 0.400 22.84 ± 3.48 <0.001 20.61 ± 9.01 0.316
Glycemic Index (U) 579.55 ± 179.16 487.29 ± 12.21 367.48 ± 131.06$$$ 685.13 ± 226.21 0.013 332.01 ± 38.04 <0.001 326.70 ± 121.11 0.131
Glycemic Load (U) 105.21 ± 43.52 63.77 ± 5.47 70.24 ± 35.70 117.32 ± 43.92 0.178 43.37 ± 5.04 <0.001 52.03 ± 26.40$ 0.008
TAC (mmol/day) 7.36 ± 3.66 10.85 ± 0.36 8.88 ± 2.72$$$ 8.22 ± 4.41 0.302 17.09 ± 0.62 <0.001 13.90 ± 5.05$$$ <0.001
HEI (points) 60.28 ± 11.92 86.21 ± 0.99 70.90 ± 12.75$$$ 56.05 ± 11.11 0.075 91.39 ± 1.80 <0.001 74.41 ± 10.07$$$ 0.836
Meal Frequency
(meals/day)
4.65 ± 0.59 3-5 4.59 ± 0.67 5.30 ± 1.25 0.001 7 N.A 6.51 ± 1.06 <0.001
CHO, Carbohydrates; PQ, Protein Quality; SFA, Saturated Fatty Acids; MUFA, Mono Unsaturated Fatty Acids; PUFA, Poly Unsaturated Fatty Acids; n-3 FA, n-3 Fatty
Acids; TAC, Total Antioxidant Capacity; HEI, Healthy Eating Index; NA, Not Applicable.
p < 0.05 was set-up as statistically significant. pa Differences between Control and RESMENA groups intake before starting the intervention. pb Differences
between Control and RESMENA scheduled diets. pc Differences between Control and RESMENA groups intake at the end of the intervention. $ Differences
between the scheduled diets and the real intake at final day in both Control and Resmena groups. $ p < 0.05; $$ p < 0.01; $$$ p < 0.001.
Lopez-Legarrea et al. Nutrition & Metabolism 2013, 10:22 Page 4 of 11
http://www.nutritionandmetabolism.com/content/10/1/22from Carlsen et al. 2010, which takes into consideration
raw or cooked food preparations [25]. They provide a list
of the total antioxidant content (mmol/100 g) of more than
3100 foods, beverages, spices, herbs and supplements used
worldwide. The TAC value corresponding to the different
scheduled/ingested servings per day was calculated. GI and
GL were obtained from Foster-Powell et al. [26] (University
of Sydney updated website database 2012).
Participants were asked to maintain their normal physical
activity during the study, estimated with a 24-h recall at the
beginning and the end of the intervention.
Anthropometric and biochemical assessments
Anthropometric measurements (body weight, height,
waist and hip circumferences) were carried out with the
subjects in their underwear. Body weight was measured to
the nearest 0.1 kg using a Tanita SC-330, (Tanita corp,
Japan). Height was estimated with a stadiometer (Seca 713model, Postfach, Germany) to the nearest 1 mm. BMI was
calculated as the body weight divided by the squared
height (kg/m2). Waist and hip circumferences were
measured with a commercial measure tap following
validated protocols [19]. Total body fat was measured by a
bioelectric impedance Tanita SC-330 (Tanita corp, Japan)
and by DXA (Lunar Prodigy, software version 6.0, Madison,
WI) as described elsewhere [19].
Glucose, total cholesterol, high density lipoprotein-
cholesterol (HDL-c), triglycerides, alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) serum
concentrations were measured in an autoanalyser Pentra
C-200 (HORIBA ABX, Madrid, Spain) with specific kits.
Insulin concentrations were determined by an enzyme-
linked immunosorbent assay kit (Mercodia, Uppsala,
Sweden) in a Triturus autoanalyzer (Grifols SA, Barcelona,
Spain). Insulin resistance was estimated by the HOMA
index {HOMA-IR = [glucose (mmol/L) × insulin (μU/ml)]/
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were calculated following the Friedewald formula: LDL-c =
TC-HDL-c - VLDL [10].
Statistical analyses
The results are expressed as mean ± SD. Normality
distributions of the measured variables were determined
according to the Shapiro–Wilk test. Differences between
the beginning and the end of the period were analyzed by
a paired t-test. Only those completely the study were
analysed. The analysis between both diets (RESMENA vs.
Control) was performed through an independent measures
t-test. A linear regression analysis was applied to assess the
potential relationships and associations among the different
components of the diet and anthropometrical and bio-
chemical parameters variation. Chi-square test was carried
out to compare the percentage of participants from Control
and RESMENA dietary groups included in the high-TAC
group. A two-way ANOVA was performed in order to
assess diet and sex interactions. Analyses were carried out
using SPSS 15.1 software for Windows (SPSS Inc, Chicago,
USA). Values of p < 0.05 were considered as statistically
significant.
Results
Food intake assessment
There were available data about food intake of 90
participants (48 from Control group and 42 from
RESMENA group). No differences were found in food
energy intake between the experimental groups at the
study baseline, except for total fat and saturated fat
intake, GI and meal frequency (Table 2).
The RESMENA group reported a significantly higher
protein and lower carbohydrate intake and the protein/
carbohydrate ratio was also higher in this group at the
end of the study (Table 2). There were no significant
differences between groups either for PQ or total fat
intake, but significant differences were found regarding
fatty acids profile (Table 2). There were no significant
differences in cholesterol intake after the intervention.
Concurrently, no differences were found in fiber intake,
neither in GI or HEI score. GL was significantly lower
(p = 0.008) and TAC significantly higher (p < 0.001) in
RESMENA group, with respect to the AHA group. As
designed, consuming the RESMENA diet had an average
intake (6.5 meals/day) significantly higher than the
control one (4.5 meals/day).
The analysis of 48-h food records showed that in both
groups the energy intake was in accordance with the
prescribed patterns (Table 2). Protein, saturated fatty
acid, polyunsaturated fatty acid (PUFA) and n-3 fatty
acids intakes, as well as GL and meal frequency of the
Control diet were in agreement with the scheduled
pattern (Table 2). RESMENA group adjusted to PUFA,cholesterol and fiber intake and also the GI and meal
frequency. RESMENA group did not reach completely
the expected values of some components although it
achieved an improvement comparing to baseline values.
Anthropometric and biochemical parameters
Energy restriction resulted in a mean body weight loss
of 6.73 ± 0.71 kg in the Control diet and 7.09 ± 0.82 kg
in the RESMENA diet, with no statistical differences be-
tween groups (Table 3). Consequently, BMI was signifi-
cantly lowered in both groups. Every anthropometrical
parameter was significantly reduced after the slimming
treatments, with no differences between both dietary
groups (Table 3). Control and RESMENA groups signifi-
cantly reduced total cholesterol and triglycerides but
there was no significant reduction in LDL-c. Only the
AHA group had a significant decrease of the HDL-c
values (p = 0.001). No changes were observed in the
atherogenic ratios TC:HDL-c and LDL-c:HDL-c in none
of the groups. Both groups significantly improved
glucose metabolism (Table 3). The Control diet, but not
the RESMENA one induced a significant reduction in ALT
(p < 0.001 vs. p = 0.936) and AST (p = 0.001 vs. p = 0.740)
transaminases levels, obtaining significant differences
among groups (Table 3). No differences between groups
were found in any of the other biochemical parameters
(Table 3).
Dietary TAC was the major influential factor, as body
weight (p = 0.034), BMI (p = 0.026), fat mass (p = 0.015)
and AST (p = 0.004) were significantly improved by this
variable (Table 4). Dietary TAC also seemed to have a
potential effect in ALT variations (p = 0.062). Concerning
GI/GL, a trend towards an influence of insulin was found
(Table 4). Since dietary TAC seemed to be the most influ-
encing variable among the dietary analyzed elements, we
categorized the sample considering the median value in:
high- TAC (> 10.629 mmol day-1) or low- TAC (<10.629
mmol day-1) (Figure 2). As expected, the percentage of
subjects from the RESMENA group (71%) included in the
high-TAC group was significantly higher (p < 0.001) as
compared with the Control group (29%). Body weight
losses were marginally (p = 0.066) different when the
subjects were categorized by the dietary TAC (Figure 2).
Thus, the group with a higher dietary TAC showed a
greater body weight reduction (−7.52 ± 0.64 kg) when
compared with the low-TAC group (−6.35 ± 0.86 kg).
Waist circumference decreased marginally towards signifi-
cant differences between the two groups (p = 0.082) being
greater in the high-TAC one (−7.77 ± 2.07 cm vs. -6.15 ±
0.31 cm). Fat mass was significantly reduced in both TAC
groups and differences between them regarding densitom-
etry fat mass kilograms (p = 0.026) were found. The low-
TAC group significantly reduces ALT (p= 0.001) and AST
(p= 0.002) transaminases levels, being statistically significant
Table 3 Changes in selected parameters in Control and RESMENA groups after 8 weeks of nutritional intervention
Variable Control group (n = 48) Resmena group (n = 48)
Visit 1 (day 0) Visit 2 (day 60) pa Visit 1 (day 0) Visit 2 (day 60) pb pc
Weight (kg) 99.45 ± 19.21 92.72 ± 18.50 <0.001 100.00 ± 16.58 92.91 ± 15.76 <0.001 0.555
BMI (kg/m2) 36.15 ± 4.95 33.70 ± 4.80 <0.001 35.55 ± 4.40 33.03 ± 4.24 <0.001 0.732
Waist circumference (cm) 110.94 ± 13.41 104.18 ± 12.29 <0.001 111.25 ± 12.30 103.78 ± 11.66 <0.001 0.432
Waist/hip ratio 0.96 ± 0.10 0.94 ± 0.09 <0.001 0.96 ± 0.10 0.93 ± 0.10 <0.001 0.355
Bioimpedance Fat mass (kg) 38.97 ± 10.87 33.68 ± 10.22 <0.001 39.23 ± 9.50 33.84 ± 9.09 <0.001 0.886
DXA Fat mass (kg) 42.13 ± 10.18 37.50 ± 10.39 <0.001 42.56 ± 9.18 37.30 ± 8.95 <0.001 0.208
TC (mg/dl) 221 ± 39 204 ± 39 0.001 219 ± 48 203 ± 46 0.020 0.943
HDL-c (mg/dl) 46 ± 10 42 ± 9 0.001 43 ± 10 41 ± 10 0.050 0.158
LDL-c (mg/dl) 140 ± 36 133 ± 35 0.085 137 ± 41 131 ± 40 0.374 0.888
TC/HDL-c ratio 4.94 ± 1.02 4.96 ± 0.94 0.856 5.18 ± 1.24 5.04 ± 1.24 0.398 0.419
LDL-c/HDL-c ratio 3.09 ± 0.77 3.22 ± 0.78 0.178 3.20 ± 0.83 3.23 ± 0.92 0.803 0.623
TG (mg/dl) 176 ± 10 145 ± 70 0.005 194 ± 123 151 ± 99 <0.001 0.421
Glucose (mg/dl) 121.02 ± 33.87 107.98 ± 13.71 0.006 123.81 ± 37.82 110.22 ± 26.18 0.016 0.939
Insulin (IU/mg) 15.30 ± 11.46 9.32 ± 7.18 <0.001 14.36 ± 8.30 9.14 ± 6.13 <0.001 0.557
HOMA index 4.69 ± 3.77 2.61 ± 2.31 <0.001 4.48 ± 3.01 2.60 ± 2.00 <0.001 0.686
ALT (U/L) 37.60 ± 21.04 27.03 ± 10.70 <0.001 29.13 ± 11.59 29.28 ± 14.20 0.936 0.001
AST (U/L) 25.81 ± 10.84 20.68 ± 6.18 0.001 21.90 ± 6.01 22.20 ± 6.14 0.740 0.002
BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG,
Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.
pa differences between baseline and final values in Control group. pb differences between baseline and final values in RESMENA group. pc differences between
changes in Control group as compared with RESMENA group at the end of the intervention.
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respectively) (Figure 2).
As expected, gender variation influenced an-
thropometrical and biochemical parameters changes
(Table 5). Body weight loss was significantly higher in
males than in females (p = 0.008), as well as fat mass
reduction (p = 0.042) (Figure 3). Interestingly, men
showed a statistically significant decrease of insulin
blood levels (p = 0.020). Concurrently, ALT values were
significantly reduced in men, while we did not found
any changes in this marker in females group (Figure 3).
Regarding dietary TAC influence, differences con-
cerning gender were found. Women with higher TAC
levels, showed a significantly greater reduction of body
weight (p = 0.019), BMI (p = 0.028) and fat mass
(p = 0.007), while there were not any variable differences
between high or low TAC in the male group.
Discussion
This study compared the effects of a novel dietary strategy
with the AHA pattern [20], considered to be effective to
counteract obesity. To our knowledge, this is a pioneer
intervention study in patients with MetS features evaluat-
ing the effects of an energy restricted diet based on food
selection, including a modified macronutrient distribution,
an increase in meal frequency, as well as the presence ofbioactive ingredients, such as fiber and n-3 fatty acids, and
controlling the GI/GL, dietary TAC and HEI score [19].
Evaluating the two prescribed dietary strategies as a
whole, both were for weight loss and improved anthropo-
metric and biochemical markers, with minor differences
between them. Waist circumference was reduced in all the
participants. However, when considering the IDF criteria
for abdominal obesity (> 90 cm. in men and > 80 cm. in
women) 4 people reached lower values after the dietary
intervention (1 man and 1 woman from the Control
group, 1 man and 1 woman from the RESMENA group).
Specifically, the individual role of each diet component
was analyzed in order to assess the dietary components
with major influence on these measurements in a MetS
sample. In this sense, several works have studied dietary
components effects separately in humans, but available
results are controversial [5,7,13].
Recent investigations have focused on the role of the
macronutrient distribution in weight reduction treatments
instead of considering only calorie restriction [27]. In this
context, increasing the dietary protein content has been a
frequently-used strategy, due to the increased satiety with
a reduction of energy intake in subsequent meals and the
higher thermogenic effect attributed to them [6,27]. Thus,
in the current work it was prescribed a dietary pattern
including the 30% of total caloric value as protein at the
expense of carbohydrates (40% total caloric value). This
Table 4 Regression analysis, with change in phenotypical measurements as dependent variable and dietary
components as the independent
Meal
Frequency
Protein
Intake
n-3 FA
intake
TAC GI GL HEI Model
p
Corrected
r2
Variable B p B p B p B p B p B p B p
Weight (Kg) 0.899 0.146 0.806 0.206 0.252 0.681 1.274 0.034 0.085 0.889 −0.519 0.399 1.140 0.059 0.024 0.122
BMI (kg/m2) 0.275 0.215 0.218 0.342 0.032 0.884 0.480 0.026 −0.025 0.910 −0.194 0.378 0.430 0.047 0.132 0.060
Waist
circumference
(cm)
0.731 0.446 1.392 0.157 −0.107 0.910 1.618 0.083 0.064 0.946 −0.722 0.447 0.624 0.508 0.559 −0.014
Bioimpedance
Fat mass (kg) 0.613 0.394 −0.036 0.962 1.358 0.053 1.185 0.091 −0.215 0.760 −0.424 0.552 0.639 0.365 0.128 0.061
DXA
Fat mass (kg) 0.949 0.063 0.819 0.120 0.434 0.392 1.211 0.015 0.050 0.921 0.154 0.763 0.806 0.109 0.133 0.059
Total
Cholesterol
(mg/dl)
3.886 0.670 0.444 0.962 −13.795 0.123 5.041 0.573 −2.462 0.783 −8.968 0.319 −16.091 0.071 0.381 0.010
HDL-c (mg/
dl)
−0.786 0.612 −2.045 0.199 −2.055 0.178 0.558 0.714 −0.951 0.531 −1.558 0.308 −0.247 0.872 0.311 0.021
LDL-c (mg/dl) 5.174 0.522 1.930 0.817 −13.268 0.095 −0.164 0.984 −2.581 0.745 −4.266 0.594 −13.979 0.077 0.348 0.015
TG (mg/dl) −2.511 0.865 2.792 0.855 7.639 0.601 23.238 0.107 5.349 0.712 −15.720 0.281 −9.324 0.522 0.471 −0.003
Glucose
(mg/dl)
3.560 0.648 −8.493 0.290 6.908 0.370 −5.614 0.464 2.408 0.753 7.928 0.303 9.467 0217 0.781 −0.035
Insulin (IU/mg) −1.662 0.233 −1.144 0.427 −1.814 0.188 −0.664 0.629 −2.546 0.061 −2.572 0.060 −1.597 0.246 0.198 −0.063
HOMA −0.539 0.299 −0.487 0.364 −0.151 0.770 −0.371 0.468 −0.666 0.190 −0.465 0.365 −0.382 0.457 0.894 0.044
ALT (U/L) −6.226 0.049 −6.852 0.035 −4.413 0.160 −5.795 0.062 3.721 0.232 3.708 0.238 5.855 0.060 0.066 0.089
AST (U/L) −3.557 0.051 −4.539 0.015 0.084 0.963 −5.046 0.004 1.610 0.371 1.580 0.384 4.699 0.008 0.020 0.131
n-3 FA, n-3 Fatty Acids; TAC, Total Antioxidant Capacity; GI, Glycemic Index: GL, Glycemic Load; HEI, Healthy Eating Index; BMI, Body Mass Index; DXA, Dual-energy
X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model
Assessment; ALT, Alanine minotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.
Figure 2 Changes on selected parameters categorized by low (<10.629 mmol day-1, n = 45) or high (>10.629 mmol day-1, n = 45) Total
Antioxidant Capacity. BMI: Body Mass Index; ALT: Alanine aminotransferase; AST: Aspartate aminotranferase. p-values comparing the differences
between low-TAC and high-TAC groups.
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Table 5 Analysis assessing diet and sex interactions concerning anthropometric and biochemical markers
Variable Groups ANOVA 2×2
Control-men
(n = 27)
Control-women
(n = 21)
RESMENA-men (n = 24) RESMENA-women (n = 24) DIET SEX Diet* sex
ΔWeight (Kg) −7.60 ± 3.29 −5.61 ± 2.49 −7.73 ± 2.58 −6.45 ± 3.09 0.416 0.007 0.550
ΔBMI (kg/m2) −2.56 ± 1.12 −2.29 ± 1.03 −2.55 ± 0.90 −2.49 ± 1.10 0.677 0.452 0.620
ΔWaist circumference (cm) −6.57 ± 4.02 −7.01 ± 5.87 −8.15 ± 2.88 −6.80 ± 4.65 0.454 0.620 0.324
ΔBioimpedance Fat mass (kg) −6.08 ± 4.92 −4.28 ± 1.84 −5.90 ± 2.64 −4.89 ± 3.50 0.764 0.054 0.582
ΔDXA Fat mass (kg) −5.13 ± 2.80 −3.99 ± 1.49 −5.71 ± 1.95 −4.78 ± 2.75 0.156 0.034 0.835
ΔTotal Cholesterol (mg/dl) −15.31 ± 35.58 −19.05 ± 30.86 −22.25 ± 44.19 −10.42 ± 49.55 0.921 0.635 0.362
ΔHDL-c (mg/dl) −2.01 ± 7.10 −6.67 ± 6.98 −0.61 ± 7.29 −3.32 ± 6.03 0.098 0.011 0.495
ΔLDL-c (mg/dl) −6.12 ± 25.04 −7.48 ± 27.41 −10.82 ± 40.17 −0.51 ± 47.30 0.880 0.553 0.440
ΔTG (mg/dl) −35.88 ± 78.11 −24.50 ± 61.90 −54.08 ± 88.48 −32.96 ± 69.79 0.399 0.304 0.757
ΔGlucose (mg/dl) −18.53 ± 36.01 −5.91 ± 19.86 −7.33 ± 26.55 −19.84 ± 46.17 0.847 0.994 0.079
ΔInsulin (IU/mg) −7.68 ± 9.02 −3.37 ± 3.58 −6.26 ± 5.02 −4.16 ± 5.25 0.690 0.022 0.486
ΔHOMA −2.64 ± 2.65 −1.35 ± 1.68 −1.74 ± 1.63 −2.02 ± 2.83 0.818 0.293 0.099
ΔALT (U/L) −13.68 ± 19.36 −6.52 ± 12.77 −3.33 ± 10.70 3.64 ± 15.38 0.001 0.026 0.975
ΔAST (U/L) −6.49 ± 11.74 −3.37 ± 6.16 −0.28 ± 6.13 0.88 ± 6.51 0.003 0.210 0.562
BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG,
Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.
Lopez-Legarrea et al. Nutrition & Metabolism 2013, 10:22 Page 8 of 11
http://www.nutritionandmetabolism.com/content/10/1/22profile did not apparently induce changes on any
anthropometrical parameters between the experimental
groups. Different studies have shown high-protein
intake effects in relation with body weight changes,
specifically on weight regain. However, those effectsFigure 3 Changes on anthropometric and biochemical selected param
HDL-c: High Density Lipoprotein-cholesterol; ALT: Alanine aminotransferase
female groups.were found in the long-term [10] while the present work
focused on the effects of an 8-week dietary treatment.
Interestingly, our study showed an inverse association be-
tween protein intake and both ALT and AST transaminases
levels. These enzymes are unspecific markers of hepaticeters regarding gender, male (n = 51) or female (n = 45).
. p -values comparing the differences between male and
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http://www.nutritionandmetabolism.com/content/10/1/22function [28]. Low-serum transaminases levels are found
under normal conditions, indicating proper function of
the liver, while increased serum values are related to
hepatic dysfunction [28]. They have shown a correlation
with insulin resistance and later development of diabetes,
liver lipid content and features of non-alcoholic fatty liver
disease. The experimental data are consistent with those
other studies and suggest that moderately-high protein
diets could influence negatively liver function. Concerning
transaminases modification, it is important to notice that
some differences were found before starting the interven-
tion. For that reason we performed a percentage of change
analyses in addition to the absolute values approach, in
order to attenuate the possible bias. However, similar
outcomes were obtained when applying this analysis,
therefore, absolute values were maintained in Table 3.
Regarding the increased meal frequency, no differences
in body weight loss in the context of iso-energetic energy-
restricted diets were found, as also was reported by
Cameron et al. 2009 [7]. Nevertheless, a direct relationship
between increased meal frequency and the loss of fat mass
was observed. With respect to biochemical parameters, no
influences were found. However, Heden et al. 2012
observed that meal frequency differentially altered
triglycerides and insulin postprandial concentrations [29].
The beneficial properties of n-3 fatty acids have been
widely studied [9,16]. In our study, a positive relationship
between n-3 fatty acids intake and the reduction of fat
mass was detected, being consistent with previous human
studies [16].
GI and GL are two concepts that refer to the absorption
rate of carbohydrates [26]. Increased values have been
reported as potential type-2 Diabetes Mellitus risk factors
[5]. In this sense, an encouraging result was obtained in
our study, since we found a trend towards a reduction in
insulin levels related to lower values of GI and GL in diet,
in agreement with Bao et al. 2010 [30].
In order to assess the quality of the diet, numerous
authors have designed and developed indexes or scores
such as the Healthy Eating Index, the Alternate Healthy
Eating Index or the Diet Quality Index and derivatives [14].
Most of them, take into consideration the Mediterranean
Diet guidelines, widely recognized as a healthy pattern [30].
They consist on a single score that results from computing
different component such as foods, food groups or a
combination of foods and nutrients. In this context the HEI
score was selected, obtained from the DIAL software. It
takes into account macro and micronutrients intake, as well
as food variety, to design the RESMENA diet. Considering
the HEI score, a trend towards influencing weight loss and
total cholesterol, LDL-c, ALT and AST levels was found.
Other works evaluating Mediterranean-based patterns
reported similar results regarding lipid metabolism and
hepatic function markers [31,32].The most relevant finding of this study is in relation to
dietary TAC. This parameter has been recently considered
as a useful tool to assess the effects of dietary antioxidants,
since it has been positively associated with plasma total
antioxidant capacity [33]. After 8 weeks of intervention, we
evidenced positive associations between the dietary TAC
and the reduction of weight, BMI, waist circumference and
fat mass. Regarding these anthropometric measurements,
our findings are in accordance with previous studies that
also reported benefits of dietary TAC and antioxidants
compounds on adiposity and obesity indicators [31,34].
This link may be associated with a reduction of cardiovas-
cular risk, as previously described in other populations [35].
We also found an effect on ALT and AST transaminases
suggesting an impact of the dietary TAC on hepatic metab-
olism. These data suggest that dietary TAC, as a measure of
antioxidant intake, must be useful to assess the role of anti-
oxidant intake as a single factor in the field of antioxidant
consumption and disease prevention or therapy.
Contrary to most of the evaluated parameters, HDL-c
values did not improve with none of the dietary
treatments, which can be explained by the fact that the
reduction on total cholesterol entails a reduction of this
cholesterol fraction too, as previously reported by other
researchers [36]. However, some other authors found
higher HDL-c serum levels after similar dietary
interventions [37] especially when containing fish or
fish derived products [16,38]. Despite our dietary strat-
egy also focused on n-3 fatty acids intake, the partici-
pants did not reach a perfect adherence to this point, so
that this can also contribute to the fact that HDL-c was
found to decrease after the dietary intervention. Other
important factor in relation to HDL-c is physical activ-
ity. In this sense, the participants were asked to main-
tain the normal activity and no exercise advice was
given, which may allow discard differences due to phys-
ical activity changes.
Differences between males and females regarding
anthropometric and biochemical parameters have been
widely investigated [1,7,39]. In this sense, we analyzed
gender influence on the studied variable changes. Body
weight loss was higher in men than women, due to the
also higher restriction regarding absolute amount of
calories. This greater reduction of weight was accompan-
ied by an also higher decrease of fat mass, as previously
reported [7]. Regarding biochemical parameters, insulin as
well as ALT blood levels were significantly decreased
within this group in accordance with previous studies [1].
On the contrary, HDL-c reduction was greater among the
women group, as other studies reported [40], which
confirms the influence of sex on this cholesterol fraction.
Taken together, these outcomes indicate that gender may
be taken into account in order to design specific dietary
plans for males and females.
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Additionally, although the adherence to the diet was
acceptable, this kind of treatments could show higher
benefits when reaching a stricter follow-up of the dietary
pattern. On the other hand, we have analyzed the effects
of this treatment on obese adults with MetS features.
The effectiveness of this pattern should be also evaluated
in a younger population since obesity and MetS rates
have increased alarmingly among childhood [41] and
they represent a development problem [42] leading to an
increased morbimortality at the adult age [43].
Conclusion
Taken together, the results of this study indicate that
RESMENA diet could be considered as a new dietary
strategy in order to improve anthropometrical and
biochemical parameters in obese subjects presenting
MetS manifestations. Furthermore, dietary TAC seems
to be, among all the analyzed dietary aspects, the most
relevant one in the obesity related markers.
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